Senate LDA lobbying filing
PFIZER INC.
Reported income
not reported
Reported expenses
$4.24M
Tracked program mentions5
Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.
H. Con. Res. 14 - Establishing the congressional budget for the US Government for FY 2025 and setting forth the…
- Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chain”matched 2+ title words
HR 2213 - Authorize the President to Enter Into Trade Agreements for the Reciprocal Elimination of Duties or Other…
H. Con. Res. 14 - Establishing the congressional budget for the US Government for FY 2025 and setting forth the…
HR 2213 - Authorize the President to Enter Into Trade Agreements for the Reciprocal Elimination of Duties or Other…
H. Con. Res. 14 - Establishing the congressional budget for the US Government for FY 2025 and setting forth the…
Lobbying activities5
Budget/AppropriationsBUD
H. Con. Res. 14 - Establishing the congressional budget for the US Government for FY 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034 Budget Reconciliation
Health IssuesHCR
S 526 - Pharmacy Benefit Manager Transparency Act of 2025 S 527 - Prescription Pricing for the People Act of 2025 S 832 - EPIC Act of 2025 S 864 - HELP Copays Act S 882 - Patients Before Middlemen Act S 1040 - Drug Competition Enhancement Act HR 946 - ORPHAN Cures Act HR 1492 - EPIC Act Biosimilars Access & Reimbursement 340B Reform 340B Access Act Inflation Reduction Act (IRA) Biosimilar Pause Inflation Reduction Act (IRA) Pill Penalty Vaccine Coverage Intellectual Property Protections PBM Reform Lower Cost More Transparency Act Bayh-Dole Act March-In Rights Cancer Policies Drug Pricing/Foreign Reference Pricing Digital Therapeutics Access & Reimbursement Patient Out of Pocket Costs
Medicare/MedicaidMMM
S 526 - Pharmacy Benefit Manager Transparency Act of 2025 S 527 - Prescription Pricing for the People Act of 2025 S 832 - Epic Act of 2025 S 864 - HELP Copays Act S 882 - Patients Before Middlemen Act HR 946 - ORPHAN Cures Act PBM Reform Medicaid Prescription Drug Access
Taxation/Internal Revenue CodeTAX
H. Con. Res. 14 - Establishing the congressional budget for the US Government for FY 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034 VICP Reform and Excise Tax Tax Cuts and Jobs Act (TCJA) Comprehensive Corporate Tax Reform
Trade (domestic/foreign)TRD
HR 2213 - Authorize the President to Enter Into Trade Agreements for the Reciprocal Elimination of Duties or Other Import Restrictions with Respect to Medical Goods Medical Supply Chain Resiliency Act International Supply Chain Tariffs Non-Tariff Trade Barriers
Lobbyists8
- ANGELA WILES
- CATHERINE ROBINSON
- ELISSA ALBEN
- EMILY MUELLER
- JENNIFER WALTON
- MATTHEW STROIA
- PAULA BURG
- STEPHEN CLAEYS
Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.